Breast cancer and drug interactions: Making sure patients get full benefit of tamoxifen treatments

Sunday, March 28, 2010 - 23:22 in Health & Medicine

Some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme, CYP2D6. In a new study, scientists have shown that by taking action as soon as interacting medications are found, patients can be weaned off and switched to a different treatment with no deleterious effect on tamoxifen metabolism.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net